These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8887622)

  • 1. Selective malabsorption and the origin of mono-rifampin-resistant Mycobacterium tuberculosis.
    Perlman DC; Salomon N
    Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1213. PubMed ID: 8887622
    [No Abstract]   [Full Text] [Related]  

  • 2. Independent origin of mono-rifampin-resistant Mycobacterium tuberculosis in patients with AIDS.
    Lutfey M; Della-Latta P; Kapur V; Palumbo LA; Gurner D; Stotzky G; Brudney K; Dobkin J; Moss A; Musser JM; Kreiswirth BN
    Am J Respir Crit Care Med; 1996 Feb; 153(2):837-40. PubMed ID: 8564140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
    Mitchison DA
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):10-5. PubMed ID: 9562106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rifabutin--a new antituberculous antibiotic].
    Antibiot Khimioter; 1997; 42(5):47-8. PubMed ID: 9254590
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk factors for rifampin mono-resistant tuberculosis.
    Ridzon R; Whitney CG; McKenna MT; Taylor JP; Ashkar SH; Nitta AT; Harvey SM; Valway S; Woodley C; Cooksey R; Onorato IM
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1881-4. PubMed ID: 9620922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rapid prediction of rifampin susceptibility of Mycobacterium tuberculosis].
    Rinder H
    Pneumologie; 1998 Feb; 52(2):91-2. PubMed ID: 9557056
    [No Abstract]   [Full Text] [Related]  

  • 7. Delayed death from pulmonary tuberculosis: unsuspected subtherapeutic drug levels.
    Morehead RS
    South Med J; 2000 May; 93(5):507-10. PubMed ID: 10832953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tuberculosis].
    Bonnaud F; Zigani A
    Rev Prat; 2002 Oct; 52(16):1809-20. PubMed ID: 12564174
    [No Abstract]   [Full Text] [Related]  

  • 9. Acquired rifampin resistance in AIDS-related TB.
    Jenny-Avital ER
    AIDS Clin Care; 2002 Aug; 14(8):72-3. PubMed ID: 12236167
    [No Abstract]   [Full Text] [Related]  

  • 10. Multidrug-resistant tuberculosis and its control.
    Kochi A; Vareldzis B; Styblo K
    Res Microbiol; 1993 Feb; 144(2):104-10. PubMed ID: 8337467
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk factors for rifampin-monoresistant tuberculosis: A case-control study.
    Sandman L; Schluger NW; Davidow AL; Bonk S
    Am J Respir Crit Care Med; 1999 Feb; 159(2):468-72. PubMed ID: 9927359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-resistant Mycobacterium tuberculosis strains in tuberculosis inpatients in Bangui, Central African Republic.
    Garin B; Di Costanzo B; Kassa Kelembho E; Legot B; Guerin D; Ouapou-Lena F; Vohito MD; Vincent V; Mathiot C
    AIDS; 1995 Feb; 9(2):213-4. PubMed ID: 7718200
    [No Abstract]   [Full Text] [Related]  

  • 13. [Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis].
    Ouedraogo M; Ouedraogo SM; Diagbouga S; Coulibaly G; Achi V; Domoua K; N'Dathz M; Yapi A
    Rev Mal Respir; 2000 Apr; 17(2):477-80. PubMed ID: 10859766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of multidrug-resistant tuberculosis treatment in HIV-positive patients in New York City, 1990-1997.
    Frieden TR; Munsiff SS; Ahuja SD
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):116. PubMed ID: 17217141
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of a commercial probe assay for detection of rifampin resistance in Mycobacterium tuberculosis directly from respiratory and nonrespiratory clinical samples.
    Gamboa F; Cardona PJ; Manterola JM; Lonca J; Matas L; Padilla E; Manzano JR; Ausina V
    Eur J Clin Microbiol Infect Dis; 1998 Mar; 17(3):189-92. PubMed ID: 9665301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in the primary resistance to Mycobacterium tuberculosis in Piedmont 1965-1979].
    Giorgis GE; Moschini MT; Bardessono F; Amelio M
    Minerva Med; 1981 Jun; 72(25):1581-6. PubMed ID: 6789249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
    Khudushina TA; Voloshina EP; Adamovich NV; Maslakova MG; Terekhova ND
    Probl Tuberk Bolezn Legk; 2005; (12):37-9. PubMed ID: 16496762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial of rifampicin in the treatment of pulmonary tuberculosis in Lagos.
    Makanjuola OO
    Niger Med J; 1973 Jul; 3(3):156-7. PubMed ID: 16366352
    [No Abstract]   [Full Text] [Related]  

  • 19. Current problems with tuberculosis treatment.
    Grosset J
    Res Microbiol; 1996; 147(1-2):10-6. PubMed ID: 8761716
    [No Abstract]   [Full Text] [Related]  

  • 20. The evaluation of anti-tuberculosis drug effects on phenotypes of Mycobacterium tuberculosis not detected by culture methods.
    Kayigire XA; Friedrich SO; van der Merwe L; Diacon AH
    Tuberculosis (Edinb); 2019 May; 116():32-34. PubMed ID: 31153515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.